Przegląd innowacyjnych technik krótkoterminowego mechanicznego wspomagania krążenia.
Keywords:
Krótkoterminowe mechaniczne wspomaganie krążenia (sMCS), Impella, TandemHeart (TH), Aortix, pRVAD, ostra niewydolność sercaSynopsis
Abstrakt: Krótkoterminowe mechaniczne wspomaganie krążenia (sMCS, short-term mechanical circulatory support) stanowi kluczowy element nowoczesnej intensywnej terapii kardiologicznej, zapewniając wsparcie hemodynamiczne u pacjentów z ostrą niewydolnością serca oraz w sczególnych przypadkach zaostrzenia przewlekłej NS. Niniejszy artykuł dokonuje przeglądu innowacyjnych przezskórnych urządzeń mechanicznego wspomagania krążenia w kontekście różnych stanów kardiologicznych. W pracy omówiono zasady działania, wskazania do stosowania oraz najbardziej nowoczesne i obiecujące techniki, takie jak pompy Impella, TandemHeart (TH), system Aortix oraz systemy pRVAD. Poniżej porównano ich mechanizmy działania, efektywność kliniczną i potencjalne powikłania, podkreślając ich znaczenie w poprawie rokowania u pacjentów. Nowoczesne sMCS stanowią pomost do odzyskania funkcji serca, transplantacji lub decyzji terapeutycznej, a ich dalszy rozwój może znacząco wpłynąć na leczenie ostrej i przewlekłej niewydolności serca.
Słowa kluczowe: Krótkoterminowe mechaniczne wspomaganie krążenia (sMCS), Impella, TandemHeart (TH), Aortix, pRVAD, ostra niewydolność serca
References
- Osaki, Satoru, et al. Improved Survival in Patients with Ventricular Assist Device Therapy: The University of Wisconsin Experience. Vol. 34, no. 2, 1 Aug. 2008, pp. 281–288, https://doi.org/10.1016/j.ejcts.2008.04.023. Accessed 12 July 2023.
-Dandel M. Cardiological Challenges Related to Long-Term Mechanical Circulatory Support for Advanced Heart Failure in Patients with Chronic Non-Ischemic Cardiomyopathy. Journal of Clinical Medicine. 2023;12(20):6451-6451. doi:https://doi.org/10.3390/jcm12206451
- Wong ASK, Sin SWC. Short-term mechanical circulatory support (intra-aortic balloon pump, Impella, extracorporeal membrane oxygenation, TandemHeart): a review. Annals of Translational Medicine. 2020;8(13):829-829. doi:https://doi.org/10.21037/atm-20-2171
-Stretch R, Sauer CM, Yuh DD, Bonde P. National Trends in the Utilization of Short-Term Mechanical Circulatory Support. Journal of the American College of Cardiology. 2014;64(14):1407-1415. doi:https://doi.org/10.1016/j.jacc.2014.07.958
-Levy B, Buzon J, Kimmoun A. Inotropes and vasopressors use in cardiogenic shock. Current Opinion in Critical Care. 2019;25(4):384-390. doi:https://doi.org/10.1097/mcc.0000000000000632
-Khalil Anouti, Gray W. The Aortix device: Support in a tube. Catheterization and Cardiovascular Interventions. 2019;93(3):434-435. doi:https://doi.org/10.1002/ccd.28136
-Huang CC, Liao PC, Ke SR, Hsu JC. TCT-21 Door-to-ECMO before Door-to-Balloon? Early Implementation of ECMO might improve the Survival of Patients with STEMI Complicated by Refractory Cardiogenic Shock. Journal of the American College of Cardiology. 2016;68(18):B9. doi:https://doi.org/10.1016/j.jacc.2016.09.897
-Tycińska A, Grygier M, Biegus J, et al. Mechanical circulatory support. An expert opinion of the Association of Intensive Cardiac Care and the Association of Cardiovascular Interventions of the Polish Cardiac Society. Kardiologia Polska. 2021;79(12):1399-1410. doi:https://doi.org/10.33963/kp.a2021.0169
-Aggarwal B, Aman W, Jeroudi O, Kleiman NS. Mechanical Circulatory Support in High-Risk Percutaneous Coronary Intervention. Methodist DeBakey Cardiovascular Journal. 2018;14(1):23-31. doi:https://doi.org/10.14797/mdcj-14-1-23
-Geller BJ, Sinha SS, Kapur NK, et al. Escalating and De-escalating Temporary Mechanical Circulatory Support in Cardiogenic Shock: A Scientific Statement From the American Heart Association. Circulation. 2022;146(6). doi:https://doi.org/10.1161/cir.0000000000001076
-Gilotra NA, Stevens GR. Temporary Mechanical Circulatory Support: A Review of the Options, Indications, and Outcomes. Clinical Medicine Insights: Cardiology. 2014;8s1:CMC.S15718. doi:https://doi.org/10.4137/cmc.s15718
- Kępka C. Novel methods in diagnostics and therapyPercutaneous left ventricular assist devices. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej. 2007;3(4):202-205.
-Koeckert MS, Jorde UP, Naka Y, Moses JW, Takayama H. Impella LP 2.5 for Left Ventricular Unloading During Venoarterial Extracorporeal Membrane Oxygenation Support. Journal of Cardiac Surgery. 2011;26(6):666-668. doi:https://doi.org/10.1111/j.1540-8191.2011.01338.x
- Spiro J, Venugopal V, Raja Y, Ludman PF, Townend JN, Doshi SN. Feasibility and efficacy of the 2.5 L and 3.8 L impella percutaneous left ventricular support device during high-risk, percutaneous coronary intervention in patients with severe aortic stenosis. Catheterization and Cardiovascular Interventions. 2014;85(6):981-989. doi:https://doi.org/10.1002/ccd.25355
- Zein R, Patel C, Mercado-Alamo A, Schreiber T, Kaki A. A Review of the Impella Devices. Interventional Cardiology: Reviews, Research, Resources. 2022;17. doi:https://doi.org/10.15420/icr.2021.11
-Dixon SR, Henriques JPS, Mauri L, et al. A Prospective Feasibility Trial Investigating the Use of the Impella 2.5 System in Patients Undergoing High-Risk Percutaneous Coronary Intervention (The PROTECT I Trial). JACC: Cardiovascular Interventions. 2009;2(2):91-96. doi:https://doi.org/10.1016/j.jcin.2008.11.005
-Saffarzadeh A, Bonde P. Options for temporary mechanical circulatory support. Journal of Thoracic Disease. 2015;7(12):2102-2111. doi:https://doi.org/10.3978/j.issn.2072-1439.2015.09.14
-Megaly M, Gandolfo C, Zakhour S, et al. Utilization of TandemHeart in cardiogenic shock: Insights from the THEME registry. Catheterization and Cardiovascular Interventions. 2023;101(4):756-763. doi:https://doi.org/10.1002/ccd.30582
-Briceño DF, Fernando RR, Nathan S, Pranav Loyalka, Kar B, Gregoric ID. TandemHeart as a Bridge to Recovery in Legionella Myocarditis. Texas Heart Institute Journal. 2015;42(4):357-361. doi:https://doi.org/10.14503/thij-14-4131
-Burkhoff D, O’Neill WW, Brunckhorst C, Letts D, Lasorda D, Cohen HA. Feasibility study of the use of the TandemHeart® percutaneous ventricular assist device for treatment of cardiogenic shock. 2006;68(2):211-217. doi:https://doi.org/10.1002/ccd.20796
-Bhandari A, Dunham A, Bassily E, Mohanty BD, Wu R. First Description of Novel End-Organ Effects by Speed Modulation Using the AortixTM Device. Case Reports in Cardiology. 2024;2024:1-6. doi:https://doi.org/10.1155/2024/7430212
- Khalil Anouti, Gray W. The Aortix device: Support in a tube. Catheterization and Cardiovascular Interventions. 2019;93(3):434-435. doi:https://doi.org/10.1002/ccd.28136
-Vora AN, W. Schuyler Jones, DeVore AD, Ebner A, Clifton W, Patel MR. First‐in‐human experience with Aortix intraaortic pump. Catheterization and Cardiovascular Interventions. 2018;93(3):428-433. doi:https://doi.org/10.1002/ccd.27857
-Cowger JA, Basir MB, Baran DA, et al. Safety and Performance of the Aortix Device in Acute Decompensated Heart Failure and Cardiorenal Syndrome. JACC Heart failure. 2023;11(11):1565-1575. doi:https://doi.org/10.1016/j.jchf.2023.06.018
-Kuchibhotla S, Esposito ML, Breton C, et al. Acute Biventricular Mechanical Circulatory Support for Cardiogenic Shock. Journal of the American Heart Association. 2017;6(10). doi:https://doi.org/10.1161/jaha.117.006670
- Harish Ravipati, Nooli NP, Hoopes CW, et al. A novel method of transapical ProtekDuo rapid deployment cannula as temporary left ventricular assist device. Journal of Surgical Case Reports. 2023;2023(6). doi:https://doi.org/10.1093/jscr/rjad246
- Schmack B, Weymann A, Popov AF, et al. Concurrent Left Ventricular Assist Device (LVAD) Implantation and Percutaneous Temporary RVAD Support via CardiacAssist Protek-Duo TandemHeart to Preempt Right Heart Failure. Medical Science Monitor Basic Research. 2016;22:53-57. doi:https://doi.org/10.12659/msmbr.898897
Published
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.